VERTEX PHARMACEUTICALS INC / MA Quarterly Return On Assets in % from Q4 2010 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly/annual Return On Assets history and growth rate from Q4 2010 to Q3 2024.
  • Vertex Pharmaceuticals Inc / Ma Return On Assets for the quarter ending September 30, 2024 was -2.16 %, a 112% decline year-over-year.
  • Vertex Pharmaceuticals Inc / Ma annual Return On Assets for 2023 was 17.3 %, a 15.9% decline from 2022.
  • Vertex Pharmaceuticals Inc / Ma annual Return On Assets for 2022 was 20.5 %, a 10.5% increase from 2021.
  • Vertex Pharmaceuticals Inc / Ma annual Return On Assets for 2021 was 18.6 %, a 27.7% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -2.16 -19.7 -112% Jul 1, 2024 Sep 30, 2024
Q2 2024 -2.21 -20.4 -112% Apr 1, 2024 Jun 30, 2024
Q1 2024 18.1 -0.66 -3.51% Jan 1, 2024 Mar 31, 2024
Q4 2023 17.3 -3.26 -15.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 17.5 -4.31 -19.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 18.1 -4.72 -20.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 18.8 +0.12 +0.64% Jan 1, 2023 Mar 31, 2023
Q4 2022 20.5 +1.95 +10.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 21.8 +3.96 +22.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 22.9 +6.05 +36% Apr 1, 2022 Jun 30, 2022
Q1 2022 18.7 -5.68 -23.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 18.6 -7.13 -27.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 17.9 -9.92 -35.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 16.8 -7.01 -29.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 24.3 +5.31 +27.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 25.7 +9.72 +60.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 27.8 -3.58 -11.4% Jul 1, 2020 Sep 30, 2020
Q2 2020 23.8 -12.4 -34.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 19 -20.6 -52% Jan 1, 2020 Mar 31, 2020
Q4 2019 16 -27.8 -63.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 31.4 +15.6 +99.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 36.3 +25.2 +228% Apr 1, 2019 Jun 30, 2019
Q1 2019 39.7 +33.2 +513% Jan 1, 2019 Mar 31, 2019
Q4 2018 43.8 +35.7 +439% Oct 1, 2018 Dec 31, 2018
Q3 2018 15.7 +9.38 +148% Jul 1, 2018 Sep 30, 2018
Q2 2018 11.1 +2.2 +24.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 6.46 +0.02 +0.31% Jan 1, 2018 Mar 31, 2018
Q4 2017 8.12 +12.4 Oct 1, 2017 Dec 31, 2017
Q3 2017 6.35 +15 Jul 1, 2017 Sep 30, 2017
Q2 2017 8.85 +19.9 Apr 1, 2017 Jun 30, 2017
Q1 2017 6.45 +22.8 Jan 1, 2017 Mar 31, 2017
Q4 2016 -4.25 +19.2 +81.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -8.62 +19.7 +69.6% Jul 1, 2016 Sep 30, 2016
Q2 2016 -11 +20.6 +65.1% Apr 1, 2016 Jun 30, 2016
Q1 2016 -16.3 +14.9 +47.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 -23.5 +9.13 +28% Oct 1, 2015 Dec 31, 2015
Q3 2015 -28.3 -5.43 -23.7% Jul 1, 2015 Sep 30, 2015
Q2 2015 -31.6 -11.2 -54.6% Apr 1, 2015 Jun 30, 2015
Q1 2015 -31.2 -16 -105% Jan 1, 2015 Mar 31, 2015
Q4 2014 -32.6 -14.6 -81% Oct 1, 2014 Dec 31, 2014
Q3 2014 -22.9 -0.98 -4.47% Jul 1, 2014 Sep 30, 2014
Q2 2014 -20.5 -1.38 -7.23% Apr 1, 2014 Jun 30, 2014
Q1 2014 -15.3 +4.08 +21.1% Jan 1, 2014 Mar 31, 2014
Q4 2013 -18 -13.9 -339% Oct 1, 2013 Dec 31, 2013
Q3 2013 -21.9 -27.1 -524% Jul 1, 2013 Sep 30, 2013
Q2 2013 -19.1 -36.7 -209% Apr 1, 2013 Jun 30, 2013
Q1 2013 -19.4 -33.5 -237% Jan 1, 2013 Mar 31, 2013
Q4 2012 -4.11 -5.66 -364% Oct 1, 2012 Dec 31, 2012
Q3 2012 5.18 +22.6 Jul 1, 2012 Sep 30, 2012
Q2 2012 17.6 +60.4 Apr 1, 2012 Jun 30, 2012
Q1 2012 14.2 +59.1 Jan 1, 2012 Mar 31, 2012
Q4 2011 1.56 +44.4 Oct 1, 2011 Dec 31, 2011
Q3 2011 -17.4 Jul 1, 2011 Sep 30, 2011
Q2 2011 -42.8 Apr 1, 2011 Jun 30, 2011
Q1 2011 -45 Jan 1, 2011 Mar 31, 2011
Q4 2010 -42.9 Oct 1, 2010 Dec 31, 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.